The Europe CRISPR market is projected to record a CAGR of 20.39% over the estimated years of 2021 to 2028. Factors such as the development of risk assessment guidelines for genetically modified plants and animals by the European Food Safety Authority (EFSA) and increasing innovations in CRISPR technologies are set to fuel the regional market’s growth.
EUROPE CRISPR MARKET FORECAST 2021-2028
Europe CRISPR Market by Product (Plasmids, Vectors, Proteins, Designing Tools, Grna, Control Kits, Library, Other Products) Market by Application (Genome Editing/genetic Engineering, CRISPR Plasmid, Human Stem Cells, Grna Database/gene Library, Cell Line Engineering) Market by End-user (Therapeutics and Drug Discovery, Biological Research, Agricultural Biotech, Industrial Biotech) by Geography
The Europe CRISPR market is projected to record a CAGR of 20.39% over the estimated years of 2021 to 2028. Factors such as the development of risk assessment guidelines for genetically modified plants and animals by the European Food Safety Authority (EFSA) and increasing innovations in CRISPR technologies are set to fuel the regional market’s growth. 
To learn more about this report, request a free sample copy
The Europe CRISPR market growth evaluation entails the assessment of Italy, Russia, the United Kingdom, Germany, France, Switzerland, the Netherlands, and the rest of Europe. Numerous researchers assert that the most contemporary applications of gene editing using CRISPR produce changes that conventional breeding could have achieved, with higher efficiency. The United Kingdom’s government broadly agrees with this perspective, as well. Furthermore, the United Kingdom’s Department for Environment, Food, and Rural Affairs (DEFRA) proposed that gene-editing technology must not be regulated in the same manner as GM if it produces a result that could have been attained by traditional breeding.
On the other hand, in 2019, an international team of scientists conducted a highly controversial experiment in Italy. Designed to test genetically modified mosquitoes, the experiment hopes to offer a robust and innovative approach to fighting malaria, considered one of the greatest scourges globally. Thus, these factors are expected to influence the CRISPR market in Europe during the forecasted period.
CRISPR Therapeutics, headquartered in Switzerland, is a gene-editing firm focused on the development of transformative gene-based medicines to treat serious human diseases. The company essentially uses its proprietary clustered, regularly interspaced, short palindromic repeats associated protein-9 (CRISPR/Cas9) gene-editing platform. Its product CTX001, an autologous CRISPR/Cas9 gene-edited hematopoietic stem cell therapy, is directed towards patients diagnosed with sickle cell disease and β-thalassemia.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- KEY DRIVERS
- RISK OF CONGENITAL ANOMALIES
- PREVALENCE OF GENETIC DISORDERS
- GROWING USE OF CRISPR IN AGRICULTURE
- RISING AWARENESS REGARDING GENE THERAPEUTICS
- KEY RESTRAINTS
- POSSIBLE MISUSE OF CRISPR GENE-EDITING TOOL
- LACK OF HEALTHCARE BUDGETS IN DEVELOPING COUNTRIES
- ETHICAL ISSUES
- KEY DRIVERS
- KEY ANALYTICS
- IMPACT OF COVID-19 ON CRISPR MARKET
- PATENT ANALYSIS
- FUNDING SCENARIO
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- KEY BUYING CRITERIA
- COST
- ACCURACY
- EASY TO USE
- LEGAL & REGULATORY FRAMEWORK
- MARKET BY PRODUCT
- PLASMIDS
- VECTORS
- PROTEINS
- DESIGNING TOOLS
- GRNA
- CONTROL KITS
- LIBRARY
- OTHER PRODUCTS
- MARKET BY APPLICATION
- GENOME EDITING/GENETIC ENGINEERING
- CRISPR PLASMID
- HUMAN STEM CELLS
- GRNA DATABASE/GENE LIBRARY
- CELL LINE ENGINEERING
- MARKET BY END-USER
- THERAPEUTICS AND DRUG DISCOVERY
- BIOLOGICAL RESEARCH
- AGRICULTURAL BIOTECH
- INDUSTRIAL BIOTECH
- GEOGRAPHICAL ANALYSIS
- EUROPE
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- UNITED KINGDOM
- GERMANY
- FRANCE
- ITALY
- RUSSIA
- NETHERLANDS
- SWITZERLAND
- REST OF EUROPE
- EUROPE
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGERS & ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- BUSINESS EXPANSIONS & DIVESTITURES
- COMPANY PROFILES
- ADDGENE
- CARIBOU BIOSCIENCES INC
- CELLECTIS BIORESEARCH SAS
- CRISPR THERAPEUTICS AG
- EDITAS MEDICINE
- GENSCRIPT
- HORIZON DISCOVERY GROUP
- INTEGRATED DNA TECHNOLOGIES
- INTELLIA THERAPEUTICS
- LONZA GROUP LTD
- NEW ENGLAND BIOLABS
- NOVARTIS INTERNATIONAL AG
- ORIGENE TECHNOLOGIES INC
- PRECISION BIOSCIENCES
- SYNTHEGO CORPORATION
- THERMO FISHER SCIENTIFIC INC
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLESÂ Â
TABLE 1: MARKET SNAPSHOT – CRISPR
TABLE 2: FUNDING SCENARIO OF PUBLIC COMPANIES
TABLE 3: FUNDING SCENARIO OF PRIVATE COMPANIES
TABLE 4: FUNDING SCENARIO OF GOVERNMENT ORGANIZATIONS
TABLE 5: REGULATORY FRAMEWORK
TABLE 6: EUROPE CRISPR MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: EUROPE CRISPR MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: EUROPE CRISPR MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: EUROPE CRISPR MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: EUROPE CRISPR MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: EUROPE CRISPR MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: EUROPE CRISPR MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: EUROPE CRISPR MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: LEADING PLAYERS OPERATING IN EUROPE CRISPR MARKET
TABLE 15: LIST OF MERGERS & ACQUISITIONS
TABLE 16: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 17: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 18: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURESÂ
FIGURE 1: FUNDING SCENARIO SHARE, BY TYPE OF COMPANIES/ORGANIZATION
FIGURE 2: KEY MARKET TRENDS
FIGURE 3: PORTER’S FIVE FORCES ANALYSIS
FIGURE 4: OPPORTUNITY MATRIX
FIGURE 5: VENDOR LANDSCAPE
FIGURE 6: KEY BUYING CRITERIA
FIGURE 7: EUROPE CRISPR MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2020
FIGURE 8: EUROPE CRISPR MARKET, BY PLASMIDS, 2021-2028 (IN $ MILLION)
FIGURE 9: EUROPE CRISPR MARKET, BY VECTORS, 2021-2028 (IN $ MILLION)
FIGURE 10: EUROPE CRISPR MARKET, BY PROTEINS, 2021-2028 (IN $ MILLION)
FIGURE 11: EUROPE CRISPR MARKET, BY DESIGNING TOOLS, 2021-2028 (IN $ MILLION)
FIGURE 12: EUROPE CRISPR MARKET, BY GRNA, 2021-2028 (IN $ MILLION)
FIGURE 13: EUROPE CRISPR MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)
FIGURE 14: EUROPE CRISPR MARKET, BY LIBRARY, 2021-2028 (IN $ MILLION)
FIGURE 15: EUROPE CRISPR MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)
FIGURE 16: EUROPE CRISPR MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2020
FIGURE 17: EUROPE CRISPR MARKET, BY GENOME EDITING/GENETIC ENGINEERING, 2021-2028 (IN $ MILLION)
FIGURE 18: EUROPE CRISPR MARKET, BY CRISPR PLASMID, 2021-2028 (IN $ MILLION)
FIGURE 19: EUROPE CRISPR MARKET, BY HUMAN STEM CELLS, 2021-2028 (IN $ MILLION)
FIGURE 20: EUROPE CRISPR MARKET, BY GRNA DATABASE/GENE LIBRARY, 2021-2028 (IN $ MILLION)
FIGURE 21: EUROPE CRISPR MARKET, BY CELL LINE ENGINEERING, 2021-2028 (IN $ MILLION)
FIGURE 22: EUROPE CRISPR MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020
FIGURE 23: EUROPE CRISPR MARKET, BY THERAPEUTICS AND DRUGS DISCOVERY, 2021-2028 (IN $ MILLION)
FIGURE 24: EUROPE CRISPR MARKET, BY BIOLOGICAL RESEARCH, 2021-2028 (IN $ MILLION)
FIGURE 25: EUROPE CRISPR MARKET, BY AGRICULTURAL BIOTECH, 2021-2028 (IN $ MILLION)
FIGURE 26: EUROPE CRISPR MARKET, BY INDUSTRIAL BIOTECH, 2021-2028 (IN $ MILLION)
FIGURE 27: EUROPE CRISPR MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 28: UNITED KINGDOM CRISPR MARKET, 2021-2028 (IN $ MILLION)
FIGURE 29: GERMANY CRISPR MARKET, 2021-2028 (IN $ MILLION)
FIGURE 30: FRANCE CRISPR MARKET, 2021-2028 (IN $ MILLION)
FIGURE 31: ITALY CRISPR MARKET, 2021-2028 (IN $ MILLION)
FIGURE 32: RUSSIA CRISPR MARKET, 2021-2028 (IN $ MILLION)
FIGURE 33: NETHERLANDS CRISPR MARKET, 2021-2028 (IN $ MILLION)
FIGURE 34: SWITZERLAND CRISPR MARKET, 2021-2028 (IN $ MILLION)
FIGURE 35: REST OF EUROPE CRISPR MARKET, 2021-2028 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- EUROPE
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- UNITED KINGDOM
- GERMANY
- FRANCE
- ITALY
- RUSSIA
- NETHERLANDS
- SWITZERLAND
- REST OF EUROPE
- EUROPE
- MARKET BY PRODUCT
- PLASMIDS
- VECTORS
- PROTEINS
- DESIGNING TOOLS
- GRNA
- CONTROL KITS
- LIBRARY
- OTHER PRODUCTS
- MARKET BY APPLICATION
- GENOME EDITING/GENETIC ENGINEERING
- CRISPR PLASMID
- HUMAN STEM CELLS
- GRNA DATABASE/GENE LIBRARY
- CELL LINE ENGINEERING
- MARKET BY END-USER
- THERAPEUTICS AND DRUG DISCOVERY
- BIOLOGICAL RESEARCH
- AGRICULTURAL BIOTECH
- INDUSTRIAL BIOTECH
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.